10.05.2016 Views

Final Program

h6okmgq

h6okmgq

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

316 TUESDAY • MAY 17<br />

C85<br />

BASIC • CLINICAL • TRANSLATIONAL<br />

BASIC SCIENCE CORE<br />

CME Credits Available: 2.0<br />

SCIENTIFIC BREAKTHROUGHS IN RNA BIOLOGY:<br />

WHAT'S NEW, EXCITING AND THERAPEUTIC!<br />

2:15 p.m. - 4:15 p.m. MOSCONE CENTER<br />

Room 2009/2011 (West Building, Level 2)<br />

Assemblies on Allergy, Immunology and Inflammation; Clinical<br />

Problems; Pulmonary Circulation; Respiratory Cell and Molecular<br />

Biology; Respiratory Structure and Function; Thoracic Oncology<br />

Target Audience<br />

Providers and trainees interested in clinical, basic and translational lung<br />

physiology, development and disease and molecular biology.<br />

Objectives<br />

At the conclusion of this session, the participant will be able to:<br />

• understand and improve knowledge of the role of Linc RNA in lung<br />

development;<br />

• understand the potential use of MicroRNAs as therapeutic targets.<br />

This session will focus on some of the recently identified and novel roles of RNA<br />

species in regulating lung development and in treating lung disease. Speakers<br />

will discuss the role of long non-coding RNA in lung development and the<br />

potential for micro RNA as therapies for lung cancer. Thus the session will span<br />

basic biology and development to cutting edge therapeutics. It will synergize<br />

with the 2016 Scientific Core theme. Presentations from experts in the field will<br />

be complemented by abstract related to the topic being discussed.<br />

Chairing: N. Kaminski, MD, New Haven, CT<br />

P.J. Sime, MD, Rochester, NY<br />

D. Erle, MD, San Francisco, CA<br />

2:15 Talk and Speaker to be Announced<br />

2:45 FENDRR is an Epigenetic Regulator of Cellular Senescence in<br />

Pulmonary Fibroblasts<br />

K. Sakamoto, MD, New Haven, CT<br />

3:00 Identification of Novel MicroRNA Targets in Neonatal Lungs of<br />

CTGF-Transgenic Mice<br />

C. Miranda, MD, Nashville, TN<br />

3:15 Monocyte-Derived Alveolar Macrophages Contribute to the<br />

Development of Lung Fibrosis and Persist in the Lung Over<br />

the Lifespan<br />

A. Misharin, PhD, Evanston, IL<br />

3:30 MicroRNA Regulation of Allergic Inflammation and Asthma<br />

K.M. Ansel, PhD, San Francisco, CA<br />

This session and the International Conference are supported by an educational grant from<br />

AstraZeneca LP.<br />

All CME sessions have been planned and implemented in accordance with the Essential<br />

Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)<br />

and are free of the control of commercial interests.<br />

C86<br />

BEHAVIORAL • CLINICAL<br />

SCIENTIFIC SYMPOSIUM<br />

CME Credits Available: 2.0<br />

Nursing Contact Hours Available: 2.4<br />

SELF-MANAGEMENT AND RISK REDUCTION<br />

CHALLENGES IN VULNERABLE POPULATIONS<br />

Assemblies on Nursing; Behavioral Science and Health Services<br />

Research; Clinical Problems<br />

2:15 p.m. - 4:15 p.m. MOSCONE CENTER<br />

Room 307 (South Building, Esplanade Level)<br />

Target Audience<br />

Nurses, physicians, physician assistants, respiratory therapists, respiratory<br />

care practitioners, pharmacists, physical therapists involved in providing or<br />

directing care in underserved populations in developed countries.<br />

Objectives<br />

At the conclusion of this session, the participant will be able to:<br />

• identify current disparities in health delivery in underserved, disenfranchised and<br />

vulnerable populations.<br />

• foster health professional attitudes to promote and frame actions to reduce<br />

disparities through identification and management of key risk factors;<br />

• look to the future of greater equity in the delivery and access to health care for<br />

all communities.<br />

This session will identify vulnerable populations across the world and discuss the<br />

unique challenges of modifying risk in these groups.<br />

Chairing: R.T. Disler, PhD, RN, Sydney, Australia<br />

L.B. Gerald, MSPH, PhD, Tucson, AZ<br />

2:15 A Patient’s Perspective<br />

D. Breslawsky, La Quinta, CA<br />

2:20 Differences in Self-Management Preferences Increases Risk of<br />

Uncontrolled Asthma in Urban Black Adults<br />

M.R. George, AE-C, PhD, RN, New York, NY<br />

2:40 Disparities in Respiratory Health in Indigenous Australians<br />

E. Tikoft, CNC, Alice Springs, Australia<br />

3:00 Tuberculosis Among Homeless People in London, United<br />

Kingdom<br />

A. Story, PhD, RN, London, United Kingdom<br />

3:20 Sexual Orientation, Respiratory Disease Risk Factors and<br />

Access to Health Care<br />

N. Sitkin, BS, New Haven, CT<br />

3:40 Children with Asthma Living in Rural Settings<br />

L. Cicutto, PhD, RN, Denver, CO<br />

4:00 Panel Discussion<br />

This session and the International Conference are supported by an educational grant from<br />

AstraZeneca LP.<br />

All CME sessions have been planned and implemented in accordance with the Essential<br />

Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)<br />

and are free of the control of commercial interests.<br />

ATS 2016 • San Francisco

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!